Moderna to cut 10% of workforce, CEO tells staff, as part of $1.5B savings effortnews2025-07-31T11:15:40+00:00July 31st, 2025|Endpoints News|
Frazier Life Sciences raises another $1.3B to create new biotech startupsnews2025-07-31T11:00:38+00:00July 31st, 2025|Endpoints News|
Lilly’s Mounjaro succeeds in cardiovascular outcomes trial, heads for expanded approvalnews2025-07-31T10:45:44+00:00July 31st, 2025|Endpoints News|
Despite Dupixent sales jump, Sanofi’s stock dips as profits fall shortnews2025-07-31T08:41:21+00:00July 31st, 2025|Endpoints News|
Teva expects to make Q3 decision on sale of API unit, CEO says news2025-07-30T19:32:59+00:00July 30th, 2025|Endpoints News|
Hospitals resume Sarepta’s gene therapy, but brace for coverage hurdlesnews2025-07-30T19:15:44+00:00July 30th, 2025|Endpoints News|
Prasad’s exit seen as positive for some biotechs, but uncertainty remainsnews2025-07-30T19:09:11+00:00July 30th, 2025|Endpoints News|
CDER director Tidmarsh will be acting head of FDA biologics center following Prasad exitnews2025-07-30T16:09:36+00:00July 30th, 2025|Endpoints News|
New data for Alzheimer’s drugs raise hopes, and questions, about bigger benefits over timenews2025-07-30T15:16:22+00:00July 30th, 2025|Endpoints News|
Merck to discontinue drug from Pandion deal; Coya’s IND for ALS drug is delayednews2025-07-30T14:44:27+00:00July 30th, 2025|Endpoints News|
